Current Ratio in % of NGM BIOPHARMACEUTICALS INC from Q3 2019 to Q4 2023

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
NGM BIOPHARMACEUTICALS INC quarterly Current Ratio history and change rate from Q3 2019 to Q4 2023.
  • NGM BIOPHARMACEUTICALS INC Current Ratio for the quarter ending 31 Dec 2023 was 718 %, a 4.45% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

NGM BIOPHARMACEUTICALS INC Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2023 718 +30.6 +4.45% 31 Dec 2023
Q3 2023 669 -17.2 -2.5% 30 Sep 2023
Q2 2023 646 -48.3 -6.96% 30 Jun 2023
Q1 2023 659 -67.2 -9.26% 31 Mar 2023
Q4 2022 687 -97.6 -12.4% 31 Dec 2022
Q3 2022 686 -140 -17% 30 Sep 2022
Q2 2022 694 -175 -20.1% 30 Jun 2022
Q1 2022 726 -154 -17.5% 31 Mar 2022
Q4 2021 785 -108 -12.1% 31 Dec 2021
Q3 2021 826 -119 -12.6% 30 Sep 2021
Q2 2021 869 -101 -10.4% 30 Jun 2021
Q1 2021 881 -87.4 -9.03% 31 Mar 2021
Q4 2020 893 +96.8 +12.2% 31 Dec 2020
Q3 2020 944 +243 +34.7% 30 Sep 2020
Q2 2020 970 30 Jun 2020
Q1 2020 968 31 Mar 2020
Q4 2019 796 31 Dec 2019
Q3 2019 701 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.